Berenberg raises target price on Chesnara.


Analysts at Berenberg raised their target price on insurance firm Chesnara from 339p to 373p on Tuesday as they updated their figures to reflect its recent acquisition of HSBC Life (UK).

Chesnara

Source: Sharecast

Berenberg stated that as part of Chesnara's £260m acquisition of HSBC Life, completed in January, the firm had acquired an operation that generates new business and that aligns with its existing product suite, particularly with its open onshore fund.

"Until now we had not included the potential benefit of this new business in our valuation, as we felt that it could potentially dilute the focus of the group and of its shareholders on the value created from life-backbook deals," said Berenberg, which reiterated its 'buy' rating on the stock.

However, given the positive market reaction to the 15 April £2bn Standard Life acquisition of Aegon Life UK, which has seen Standard Life's share price rise by roughly 10%, the German bank now believes that there has been "increased investor interest in new business growth" in UK life insurance.

"While we maintain our forecast 3% DPS growth, in line with Chesnara's 20-year continuous DPS growth track record, we raise our dividend-discount-based valuation to reflect the benefit of the fall in UK equity risk premiums. We cut the discount rate we use to discount future dividend growth from 9.2% to 8.9%," added Berenberg.

Reporting by Iain Gilbert at Sharecast.com


ISIN: GB00B00FPT80
Exchange: London Stock Exchange
Sell:
325.00 p
Buy:
326.00 p
Change: 4.50 ( 1.40 %)
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.